(Q37888068)

English

Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines

scientific article published on 12 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Brian Greenwood

2

object named as

Brian Greenwood

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

David L. Heymann

7

object named as

David L Heymann

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

author name string

James R Hargreaves

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Charles Clift

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Akshay Goel

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Anne Roemer-Mahler

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Richard Smith

6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

language of work or name

0 references

publication date

12 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

378

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

9806

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1885-1893

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal C conjugate vaccine: the experience in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Global epidemiology of meningococcal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal carriage in the African meningitis belt

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Saving the pneumococcal AMC and GAVI

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

GAVI's Advance Market Commitment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal group A, C, Y and W-135 conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Beyond patents: the GAVI Alliance, AMCs and improving immunization coverage through public sector vaccine production in the global south

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Making practical markets for vaccines. Why I decided that the Center for Global Development Report, Making Markets for Vaccines, offers poor advice to government and foundation leaders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten years of the Global Alliance for Vaccines and Immunisation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

High time for GAVI to push for lower prices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960687-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(11)60687-9

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37888068&oldid=1755901197"